David Einhorn
Greenlight Capital
David Einhorn Sotera Health Co stake
total: 357
Greenlight Capital SHC trades
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 2
- Held since:
- 2025 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, David Einhorn holds 4,135,515 Sotera Health Co (SHC) shares with a market value of roughly $73.41M accounting for 1.88% of the overall portfolio. To date, the estimated cost basis is nearly $16.07 for "buy" trades and estimated average "sell" price is $15.73. Greenlight Capital first purchased SHC in 2023 Q2, initially acquiring 5,450 shares. David Einhorn later completely sold out the position and invested in Sotera Health Co again in 2025 Q2. Since the initial investment in Sotera Health Co (SHC), Greenlight Capital has made 8 more transactions.
When did David Einhorn buy Sotera Health Co (SHC)?
David Einhorn first invested in Sotera Health Co (SHC) in 2023 Q2 at the reported quarter-end price of $18.84 per share.
What's the cost basis of Greenlight Capital's SHC stake?
The estimated cost basis for Sotera Health Co (SHC) stake is around $16.07 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $16.07
- Weighted AVG sell price:
- $15.73
David Einhorn's historical trades in Sotera Health Co
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.88%
|
4,135,515
|
$17.75
|
$73,405,392
|
+100.20% (+2,069,835)
|
+0.94%
|
|
2026 Q1
|
0.93%
|
2,065,680
|
$14.34
|
$29,621,851
|
+347.82% (+1,604,410)
|
+0.72%
|
|
2025 Q4
|
0.29%
|
461,270
|
$17.64
|
$8,136,803
|
+155.44% (+280,690)
|
+0.17%
|
|
2025 Q3
|
0.11%
|
180,580
|
$15.73
|
$2,840,524
|
-22.73% (-53,110)
|
-0.04%
|
|
2025 Q2
|
0.11%
|
233,690
|
$11.12
|
$2,598,632
|
new
|
+0.11%
|
|
2024 Q3
|
0.00%
|
0
|
$11.87
|
|
-100% (-300,110)
|
-0.17%
|
|
2024 Q1
|
0.16%
|
300,110
|
$12.01
|
$3,604,321
|
-10.94% (-36,860)
|
-0.02%
|
|
2023 Q3
|
0.29%
|
336,970
|
$14.98
|
$5,047,810
|
+6,082.94% (+331,520)
|
+0.28%
|
|
2023 Q2
|
0.00%
|
5,450
|
$18.84
|
$102,678
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.